COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2

NCT01639664 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
115
Enrollment
OTHER
Sponsor class

Stopped The interim analysis requested by the EDSMC shows higher mortality for the CPFA group compared to the controls, particularly in the first days of treatment.

Conditions

Interventions

Sponsor

Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva

Collaborators